Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Vial will be at the East-West Biopharma Summit

November 14-16, 2022 | Redwood City, CA

Vial is proud to attend the BioCenturt-BayHelix East-West Biopharma Summit organized by BioCentury and BayHelix in collaboration with McKinsey & Company.

Meet with us

Let us know if you’d like to connect with us before or at the event by submitting the form below.

Vial staff attending the event:

Andrew Brackin
Co-founder & Chief Revenue Officer

Meet with us!

Name(Required)
By submitting, you are agreeing to our terms and privacy policy